AU2001253051A1 - A novel specific inhibitor of the cyclin kinase inhibitor p21waf1/cip1 - Google Patents

A novel specific inhibitor of the cyclin kinase inhibitor p21waf1/cip1

Info

Publication number
AU2001253051A1
AU2001253051A1 AU2001253051A AU5305101A AU2001253051A1 AU 2001253051 A1 AU2001253051 A1 AU 2001253051A1 AU 2001253051 A AU2001253051 A AU 2001253051A AU 5305101 A AU5305101 A AU 5305101A AU 2001253051 A1 AU2001253051 A1 AU 2001253051A1
Authority
AU
Australia
Prior art keywords
inhibitor
cip1
p21waf1
novel specific
cyclin kinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001253051A
Other languages
English (en)
Inventor
Robert H. Weiss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Veterans Affairs
Original Assignee
US Department O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department O filed Critical US Department O
Publication of AU2001253051A1 publication Critical patent/AU2001253051A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001253051A 2000-03-29 2001-03-30 A novel specific inhibitor of the cyclin kinase inhibitor p21waf1/cip1 Abandoned AU2001253051A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19315500P 2000-03-29 2000-03-29
US60193155 2000-03-29
PCT/US2001/010443 WO2001088191A1 (fr) 2000-03-29 2001-03-29 Un nouvel inhibiteur specifique de l'inhibiteur p21waf1cip1

Publications (1)

Publication Number Publication Date
AU2001253051A1 true AU2001253051A1 (en) 2001-11-26

Family

ID=22712455

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001253051A Abandoned AU2001253051A1 (en) 2000-03-29 2001-03-30 A novel specific inhibitor of the cyclin kinase inhibitor p21waf1/cip1

Country Status (3)

Country Link
US (1) US20030144236A1 (fr)
AU (1) AU2001253051A1 (fr)
WO (1) WO2001088191A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2494236A1 (fr) * 2002-08-07 2004-02-19 Exelixis, Inc. Genes csnk1gs utilises en tant que modificateurs de la voie p21 et procede d'utilisation associe
US8288439B2 (en) 2003-11-04 2012-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the inhibition of HIV-1 replication
US20050137122A1 (en) * 2003-12-17 2005-06-23 Alcon, Inc. Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance
WO2011097354A1 (fr) 2010-02-05 2011-08-11 Deland M Maitland Traitement par del de toxicités dermatologiques associées à des inhibiteurs de multikinases
WO2011097360A1 (fr) * 2010-02-05 2011-08-11 Deland M Maitland Utilisation de del pour le traitement de lésions dermatologiques associées à des inhibiteurs des récepteurs du facteur de croissance épidermique
WO2011097358A1 (fr) * 2010-02-05 2011-08-11 Deland M Maitland Utilisation de del pour le traitement de lésions dermatologiques associées à des inhibiteurs du facteur de croissance endothéliale vasculaire
US10264976B2 (en) * 2014-12-26 2019-04-23 The University Of Akron Biocompatible flavonoid compounds for organelle and cell imaging

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5863904A (en) * 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21

Also Published As

Publication number Publication date
WO2001088191A1 (fr) 2001-11-22
US20030144236A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
AU2001254798A1 (en) Scale removal
AU2001250554A1 (en) Mp 3 jukebox
AU2001258771A1 (en) -secretase inhibitors
AU2001292518A1 (en) Novel compounds
AU5531599A (en) Novel cdk inhibitors having flavone structure
AU2001246998A1 (en) Novel compounds
AU2001239765A1 (en) Novel compounds
AU2000261840A1 (en) Bis-beta-hydroxyethyl terephthalate
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2002231077A1 (en) Novel compounds
AU2002219900A1 (en) Minimal identification of features
AU2001256964A1 (en) Novel compounds
AU2001253051A1 (en) A novel specific inhibitor of the cyclin kinase inhibitor p21waf1/cip1
AU2001230689A1 (en) Novel compounds
AU2001232132A1 (en) Novel assay
AU2002216060A1 (en) Novel compounds
AU2001282644A1 (en) Case
AU2001256161A1 (en) Nail
AU2001276890A1 (en) Novel compounds
AU2001233965A1 (en) Novel cd23 inhibitors
AU2001240793A1 (en) Novel assay
AU2001258760A1 (en) Novel thiophenamide compounds
AU2001237533A1 (en) Novel p-gp-inhibiting compounds
AU2002219846A1 (en) Novel use